Polyphenol-rich Citrullus lanatus rind extract (500 mg/kg/day) mitigated doxorubicin-induced cardiotoxicity in rats, restoring antioxidant biomarkers and reducing inflammatory cytokines.
Does polyphenol-rich Citrullus lanatus rind extract mitigate doxorubicin-induced cardiotoxicity in rats?
Polyphenol-rich Citrullus lanatus rind extract demonstrates antioxidant and cardioprotective properties against doxorubicin-induced cardiotoxicity in a rat model.
Background/Objectives: Cardiovascular diseases (CVDs) remain a major cause of mortality globally, driven in part by oxidative stress and inflammation. The present study investigated the polyphenolic composition and cardioprotective potential of polyphenol-rich Citrullus lanatus (PRCL) rind extract against doxorubicin-induced cardiotoxicity in rats; Methods: High-performance liquid chromatography (HPLC) was employed to identify and quantify the major bioactive compounds present in the extract. Total 30 healthy male Wistar Kyoto rats were recruited and divided into 6 groups and various cardiovascular markers and antioxidant were measured in vivo and in vitro methods; Results: Ethanolic extraction of Citrullus lanatus rind yielded 19.58 g extract per 100 g of dry plant material. HPLC analysis identified five phenolic acids, i.e., gallic acid, p-hydroxybenzoic acid (PHBA), chlorogenic acid, caffeic acid, and vanillic acid, and two flavonoids, i.e., catechin and hesperetin, with PHBA (163.66 mg/g of extract) being the most abundant. Total phenolic and flavonoid content was determined to be 35.6 mg GAE/g and 12.8 mg CE/g, respectively. In vitro antioxidant assays showed moderate free radical scavenging, reducing power, and 86.9% inhibition of linoleic acid peroxidation. In vivo, Wistar rats were treated with doxorubicin (10 mg/kg) to induce cardiotoxicity, followed by PRCL extract administration (21 days at 250 and 500 mg/kg/day). The extract significantly improved body weight, serum lipid profile, and reduced cardiovascular risk indices. Antioxidant biomarkers (SOD, CAT, GPx, GSH) were restored, while lipid peroxidation (MDA) and inflammatory cytokines (TNF-α, IL-6) were significantly reduced in treated groups. The 500 mg/kg dose demonstrated superior efficacy, comparable to the standard quercetin group. Histopathological examination revealed notable protection of cardiac tissue architecture in the high-dose PRCL-500 group; Conclusions: These findings suggest that PRCL rind extract contains potent compounds having antioxidant and cardioprotective properties and may be used as a natural therapeutic agent against cardiotoxicity.
Bader Alsuwayt (Fri,) conducted a other in Doxorubicin-induced cardiotoxicity (n=30). Polyphenol-rich Citrullus lanatus (PRCL) rind extract vs. Doxorubicin alone and standard quercetin was evaluated on Cardiovascular markers, antioxidant biomarkers, lipid peroxidation, and inflammatory cytokines. Polyphenol-rich Citrullus lanatus rind extract (500 mg/kg/day) mitigated doxorubicin-induced cardiotoxicity in rats, restoring antioxidant biomarkers and reducing inflammatory cytokines.